"Inspiring Innovation" HSLU TEDx Event - "Resilience: Key to Successful Innovation"
Subgroup Analyses: Can We Smooth' out the Rough Edges? Daniel Sargent, PhD Mayo Clinic Sept 28, 2006.
ETAS_MCQ_02 immunodermatology
Monoclonal Antibodies and their role in Pharmacology
ASCO 2010 Review: Gastric and Esophageal Cancer
2013. cancer congress
1Kitasato-Harvard Symposium 10/03/2002 New Monoclonal Antibody Approved for Advanced Breast Cancer Shin-ichi Nihira, Ph.D. Dept. Clinical Research 3 Chugai.
A Phase Ib/II Trial of Trastuzumab-DM1 (T-DM1) with Pertuzumab for Women with HER2-Positive Locally-Advanced or Metastatic Breast Cancer who were Previously.
ALZHEIMER RESEARCH ADVANCES JOAN SMITH SONNEBORN, PHD. PROFESSOR EMERITUS UNIVERSITY OF WYOMING ZOOLOGY & PHYSIOLOGY.
A Phase III, Randomized, Double-Blind, Placebo-Controlled Registration Trial to Evaluate the Efficacy and Safety of Placebo + Trastuzumab + Docetaxel vs.
Randomized Phase II Trial of Cetuximab/Bevacizumab/Irinotecan versus Cetuximab/Bevacizumab in Irinotecan-Refractory Colorectal Cancer LB Saltz, HJ Lenz,
research
